Analysis of Cytokirre mRNA Profiles in the Lungs of Pneumocystis carinii-infected Mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 17, Issue 4, 1997, Pages 491-500

  Wright, Terry W ^a   Johnston, Carl J ^a   Harmsen, Allen G ^a   Finkelstein, Jacob N ^a  

^a Department of Pediatrics ^*

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCYSTIS CARINII;

CYTOKINE; MESSENGER RNA;

ANIMAL; ARTICLE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IN SITU HYBRIDIZATION; LUNG; MOUSE; PATHOLOGY; PNEUMOCYSTIS; PNEUMOCYSTIS PNEUMONIA;

ANIMALS; CYTOKINES; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; LUNG; MICE; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS; RNA, MESSENGER;

EID: 0031255756     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.17.4.2851     Document Type: Article

References (50)

1. Walzer, P. D., D. P. Perl, D. J. Krogstad, P. G. Rawson, and M. G. Schultz. 1974. Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic and clinical features. Ann. Intern. Med. 80:83-89.
2. Rao, C. P., and E. W. Gelfand. 1983. Pneumocystis carinii pneumonitis in patients with hypogammaglobulinemia and intact T cell immunity. J. Pediatr. 103:410-412.
3. Marcotte, H., D. Levesque, K. Delaney, A. Bourgeault, R. de la Durantaye, S. Brochu, and M. C. Lavoie. 1996. Pneumocystis carinii infection in transgenic B cell-deficient mice. J. Infect. Dis. 173:1034-1037.
4. Rosen, M. J. 1992. Pulmonary complications of HIV infection. Mt. Sinai J. Med. 59:263-270.
5. + cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172: 937-945.
6. Hanano, R., K. Reifenberg, and S. H. E. Kaufman. 1996. Naturally acquired Pneumocystis carinii pneumonia in gene disruption mutant mice: roles of distinct T-cell populations in infection. Infect. Immun. 64:3201-3209.
7. Shellito, J. E., V. V. Suzara, W. Blumenfeld, J. M. Beck, H. J. Steger, and T. H. Ermak. 1990. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J. Clin. Invest. 85:1686-1693.
8. + T-cells into severe combined immunodeficiency mice. J. Clin. Invest. 90: 673-678.
9. Wiley, J. A., and A. G. Harmsen. 1995. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J. Immunol. 155:3525-3529.
10. Roths, J. B., J. D. Marshall, R. D. Allen, G. A. Carlson, and C. L. Sidman. , 1990. Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice. Am. J. Pathol. 136:1173-1186.
11. Chen, W., J. W. Mills, and A. G. Harmsen. 1992. Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses. Int. J. Exp. Pathol. 73:709-720.
12. Kanaly, S. T., S. A. Hines, and G. H. Palmer. 1995. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect. Immun. 63:3037-3041.
13. Mo, X. Y., S. R. Sarawar, and P. C. Doherty. 1995. Induction of cytokines in mice with parainfluenza pneumonia. J. Virol. 69:1288-1291.
14. Kawakami, K., S. Kohno, J. Kadota, M. Tohyama, K. Teruya, N. Kudeken, A. Saito, and K. Hara. 1995. T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice innoculated with heat-killed Cryptococcus neoformans: involvement of IFN-gamma and its protective effect against cryptococcal infection. Microbiol. Immunol. 39:135-143.
15. Chen, W., E. A. Havell, L. L. Moldawer, K. W. McIntyre, R. A. Chizzonite, and A. G. Harmsen. 1992. Interleukin 1: an important mediator of host resistance against Pneumocystis carinii. J. Exp. Med. 176:713-718.
16. Chen, W., E. A. Havell, and A. G. Harmsen. 1992. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect. Immun. 60:1279-1284.
17. Ishimine, T., K. Kawakami, A. Nakamoto, and A. Saito. 1995. Analysis of cellular response and gamma interferon synthesis in bronchoalveolar lavage fluid and lung homogenate of mice infected with Pneumocystis carinii. Microbiol. Immunol. 39:49-58.
18. Chen, W., E. A. Havell, F. Gigliotti, and A. G. Harmsen. 1993. Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response. Infect. Immun. 61:97-102.
19. Mandujano, J. F., N. B. D'Souza, S. Nelson, W. R. Summer, R. C. Beckerman, and J. E. Shellito. 1995. Granulocyte-macrophage colony stimulating factor and Pneumocystis carinii pneumonia in mice. Am. J. Respir. Crit. Care Med. 151:1233-1238.
20. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173. (Abstr.)
21. Cavaillon, J. M. 1994. Cytokines and macrophages. Biomed. Pharmacother. 48:445-453.
22. Fels, A. O. S., and Z. A. Cohn. 1986. The alveolar macrophage. J. Appl. Physiol. 60:353-369.
23. Stadnyk, A. W. 1994. Cytokine production by epithelial cells. FASEB J. 8:1041-1047.
24. Sher, A., and R. L. Coffman. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:385-409.
25. + T-cells from young and old mice. J. Immunol. 150:3602-3614.
26. Melton, D. A., P. A. Krieg, M. R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nuc. Acids Res. 12:7035-7056.
27. Angerer, L. M., K. H. Cox, and R. C. Angerer. 1987. Demonstration of tissue-specific gene expression by in situ hybridization. Methods Enzymol. 152:649-661.
28. Stout, R. D., J. Suttles, J. Xu, I. S. Grewal, and R. A. Flavell. 1996. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156:8-11.
29. Stevens, M. G., J. H. Exon, and D. P. Olson. 1989. In vivo effects of interferon-gamma and indomethacin on murine alveolar macrophage activity. Cell. Immunol. 123:83-95.
30. Frendl, G. 1992. Interleukin 3: from colony-stimulating factor to pluripotent immunoregulatory cytokine. Int. J. Immunopharm. 14:421-430.
31. Masur, H., and T. C. Jones. 1978. The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J. Exp. Med. 147:157-170.
32. Von Behren, L. A., and E. L. Pesanti. 1978. Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Am. Rev. Respir. Dis. 118: 1051-1059.
33. Kandil, O., J. A. Fishman, H. Koziel, P. Pinkston, R. M. Rose, and H. G. Remold. 1994. Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect. Immun. 62:644-650.
34. Ezckowitz, R. A. B., D. J. Williams, H. Koziel, M. Y. K. Armstrong, A. Warner, F. F. Richards, and R. M. Rose. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351:155-158.
35. O'Riordan, D. M., J. E. Standing, K. Y. Kwon, D. Chang, E. C. Crouch, and A. H. Limper. 1995. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J. Clin. Invest. 95:2699-2710.
36. Neese, L. W., J. E. Standing, E. J. Olson, M. Castro, and A. H. Limper. 1994. Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNF-α in response to Pneumocystis carinii. J. Immunol. 152: 4549-4556.
37. + T lymphocyte depletion attenuates lipopolysaccharide-induced tumor necrosis factor secretion by alveolar macrophages in the mouse. Lymph. Cyt. Res. 13:359-366.
38. + T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur. J. Immunol. 24:3148-3154.
39. Ulich, T. R., L. R. Watson, S. M. Yin, K. Z. Guo, P. Wang, H. Thang, and J. Del Castillo. 1991. The intratracheal administration of endotoxin and cytokines. I. Characterization of LPs-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate. Am. J. Pathol. 138:1485-1496.
40. + lymphocyte-depleted mice given aerosols of heat-treated Escherichia coli. J. Exp. Med. 176:881-886.
41. + T lymphocytes. J. Immunol. 152:1523-1531.
42. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617-620.
43. Holsti, M. A., and D. H. Raulet. 1989. IL-6 and IL-1 synergize to stimulate IL-2 production and proliferation of peripheral T cells. J. Immunol. 143: 2514-2519.
44. Smith, K. A. 1984. Interleukin 2. Annu. Rev. Immunol. 2:319-333.
45. Yokota, S., T. D. Geppert, and P. E. Lipsky. 1988. Enhancement of antigen-and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-α. J. Immunol. 140:531-536.
46. Shalaby, M. R., T. Espevik, G. C. Rice, A. J. Ammann, I. S. Figari, G. E. Ranges, and M. A. Palladino. 1988. The involvement of human tumor necrosis factors-α and -β in the mixed lymphocyte reaction. J. Immunol. 141:499-503.
47. Bricland, J. K., J. M. Flory, M. L. Jones, G. R. Miller, D. G. Remick, J. S. Warren, and J. C. Fantone. 1995. Regulation of monocyte chemoaltractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1 beta. Am. J. Respir. Cell Mol. Biol. 12:104-109.
48. Karmann, K., W. Min, W. C. Fanslow, and J. S. Pober. 1996. Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. J. Exp. Med. 184:173-182.
49. Bogdan, C., H. Moll, W. Solbach, and M. Rollinghoff. 1990. Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates mutine macrophages for elimination of Leishmania major amastigotes. Eur. J. Immunol. 20:1131-1135.
50. Cluitmans, F. H., B. H. Esendam, J. E. Landegent, R. Willemze, and J. H. Falkenburg. 1993. Regulatory effects of T cell lymphokines on cytokine gene expression in monocytes. Lymph. Cyt. Res. 12:457-464.